June 8, 2026Financings for June 8, 2026Biopharma and med-tech companies raising money in public or private financings, including: Dicot, Iqvia, Nrx, Seres, Vivos.
June 5, 2026Financings for June 5, 2026Biopharma and med-tech companies raising money in public or private financings, including: Artan, Celcuity, Cerevasc, Imunon, Jade, Olix, Parabilis.
June 5, 2026By Amanda LanierHemab soars 89% on debut as biopharma IPOs stay strong in MayTotal biopharma financing through the first five months of 2026 reached $49.46 billion, the third-highest total for the period in the dataset and more than doubling of 2025’s $21.4 billion over the same stretch.
